Thermo Fisher Scientific Inc. (TMO) Holdings Trimmed by Webster Bank N. A.
Webster Bank N. A. reduced its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.6% during the fourth quarter, Holdings Channel reports. The institutional investor owned 30,845 shares of the medical research company’s stock after selling 825 shares during the period. Webster Bank N. A.’s holdings in Thermo Fisher Scientific were worth $5,857,000 as of its most recent filing with the SEC.
Other institutional investors have also bought and sold shares of the company. Amalgamated Bank lifted its position in shares of Thermo Fisher Scientific by 57.0% in the 2nd quarter. Amalgamated Bank now owns 44,921 shares of the medical research company’s stock worth $7,837,000 after buying an additional 16,308 shares during the last quarter. Mutual of America Capital Management LLC lifted its position in shares of Thermo Fisher Scientific by 2.1% in the 2nd quarter. Mutual of America Capital Management LLC now owns 47,728 shares of the medical research company’s stock worth $8,327,000 after buying an additional 977 shares during the last quarter. Americafirst Capital Management LLC bought a new position in shares of Thermo Fisher Scientific in the 3rd quarter worth about $876,000. State Board of Administration of Florida Retirement System lifted its position in shares of Thermo Fisher Scientific by 0.9% in the 2nd quarter. State Board of Administration of Florida Retirement System now owns 580,712 shares of the medical research company’s stock worth $101,317,000 after buying an additional 5,213 shares during the last quarter. Finally, San Francisco Sentry Investment Group CA bought a new position in shares of Thermo Fisher Scientific in the 2nd quarter worth about $1,451,000. Institutional investors own 86.22% of the company’s stock.
In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the sale, the chief executive officer now directly owns 302,577 shares in the company, valued at approximately $58,016,113.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.49% of the stock is currently owned by insiders.
Shares of Thermo Fisher Scientific Inc. (TMO) traded up $1.81 during trading hours on Tuesday, reaching $215.32. 1,230,200 shares of the company traded hands, compared to its average volume of 1,552,686. The company has a market cap of $85,670.00, a P/E ratio of 36.56, a PEG ratio of 1.74 and a beta of 1.06. Thermo Fisher Scientific Inc. has a 12-month low of $140.00 and a 12-month high of $215.33. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26.
Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the previous year, the firm earned $2.03 EPS. Thermo Fisher Scientific’s revenue was up 13.9% on a year-over-year basis. sell-side analysts anticipate that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Monday, January 15th. Shareholders of record on Friday, December 15th were given a dividend of $0.15 per share. The ex-dividend date was Thursday, December 14th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.28%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.19%.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.